Awakn Life Sciences Archives

Psychedelics News

Awakn Life Sciences

Psychedelic Titans

10 Aug 2021

Psychedelic Titans with Ben Sessa of Awakn Life Sciences

This week's Psychedelic Guide is Ben Sessa, Chief Medical Officer & Consultant Psychiatrist for Awakn Life Sciences...

By Microdose

Press Releases

23 Jun 2021

Awakn Life Sciences to Commence Trading on the NEO Exchange under the Symbol ‘AWKN’

TORONTO, Ontario, June 23, 2021 – Awakn Life Sciences Corp....

By Microdose

Press Releases

17 Jun 2021

Awakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release From Escrow Of Private Placement Proceeds, And Final Approval For Listing On Neo Exchange

Vancouver, B....

By Microdose

Press Releases

8 Jun 2021

Awakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds Of $8.3 Million

Vancouver, B....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

9 Mar 2021

Awakn Acquires Proprietary Next Generation MDMA and Ketamine Data from Prof. David Nutt

London, United Kingdom–(Newsfile Corp....

By Microdose

Press Releases

2 Mar 2021

Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial

London, United Kingdom-(Newsfile Corp....

By Microdose

Press Releases

19 Feb 2021

Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial

London, United Kingdom–(Newsfile Corp....

By Microdose

Press Releases

25 Jan 2021

Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

London, United Kingdom–(Newsfile Corp....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result